Its essential to follow the dosage and monitoring instructions provided to maximize benefits and minimize side effects
Starting too aggressively can increase the likelihood of side effects, while increasing too slowly may delay results for patients who need stronger metabolic support
In the 70s, other appetite suppressants appeared on the scene, recommended for safe (but limited) usage
Long-term, GLP-1 medications appear to lower uric acid and reduce flares
A patient in a medically supervised program can receive guidance on protein targets, exercise strategy, dose tolerance, hydration, digestion, lab markers, and adjunctive therapies when appropriate
An MHRA spokesperson said: Alongside increased usage, we are seeing an upturn in the number of Yellow Card reports mentioning GLP-1 medicines and acute pancreatitis. Due to the impact of this serious disease on patients, the MHRA said it wanted to understand whether there were any genetic factors at play